CONVERSION TRIAL FROM MYCOPHENOLATE MOFETIL (MMF) TO ENTERIC-COATED MYCOPHENOLATE SODIUM (EC-MPS) IN STABLE TRANSPLANTED PATIENTS SUFFERING FROM GASTROINTESTINAL (GI) ADVERSE EVENTS WHILE ON MYCOPHENOLATE MOFETIL THERAPY (MMF) THERAPY: